EZH2 couples pancreatic regeneration to neoplastic progression

被引:99
作者
Mallen-St Clair, Jon [1 ]
Soydaner-Azeloglu, Rengin [1 ]
Lee, Kyoung Eun [1 ]
Taylor, Laura [1 ]
Livanos, Alexandra
Pylayeva-Gupta, Yuliya [1 ]
Miller, George [2 ]
Margueron, Raphael [1 ]
Reinberg, Danny [1 ,3 ]
Bar-Sagi, Dafna [1 ]
机构
[1] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA
[2] NYU, Sch Med, Dept Surg, New York, NY 10016 USA
[3] Howard Hughes Med Inst, New York, NY 10016 USA
关键词
EZH2; pancreas; regeneration; cancer; TUMOR-CELL PROLIFERATION; ACINAR-CELL; BETA-CELL; EXPRESSION; CANCER; INFLAMMATION; METHYLATION; ENHANCER; HEDGEHOG; GENE;
D O I
10.1101/gad.181800.111
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Although the polycomb group protein Enhancer of Zeste Homolog 2 (EZH2) is well recognized for its role as a key regulator of cell differentiation, its involvement in tissue regeneration is largely unknown. Here we show that EZH2 is up-regulated following cerulein-induced pancreatic injury and is required for tissue repair by promoting the regenerative proliferation of progenitor cells. Loss of EZH2 results in impaired pancreatic regeneration and accelerates KRas(G12D)-driven neoplasia. Our findings implicate EZH2 in constraining neoplastic progression through homeostatic mechanisms that control pancreatic regeneration and provide insights into the documented link between chronic pancreatic injury and an increased risk for pancreatic cancer.
引用
收藏
页码:439 / 444
页数:6
相关论文
共 50 条
  • [1] Update of research on the role of EZH2 in cancer progression
    Shen, Liang
    Cui, Jing
    Liang, Shumei
    Pang, Yingxin
    Liu, Peishu
    ONCOTARGETS AND THERAPY, 2013, 6 : 321 - 324
  • [2] EZH2, a Potential Regulator of Dental Pulp Inflammation and Regeneration
    Hui, Tianqian
    Peng, A.
    Zhao, Yuan
    Wang, Chenglin
    Gao, Bo
    Zhang, Ping
    Wang, Jun
    Zhou, Xuedong
    Ye, Ling
    JOURNAL OF ENDODONTICS, 2014, 40 (08) : 1132 - 1138
  • [3] Review: Targeting EZH2 in neuroblastoma
    Gao, Jinhui
    Fosbrook, Claire
    Gibson, Jane
    Underwood, Timothy J.
    Gray, Juliet C.
    Walters, Zoe S.
    CANCER TREATMENT REVIEWS, 2023, 119
  • [4] Robust expression of EZH2 in endocervical neoplastic lesions
    Makk, Evelin
    Balint, Levente
    Cifra, Janos
    Tornoczky, Lamas
    Oszter, Angela
    Toth, Arnold
    Kalman, Endre
    Kovacs, Krisztina
    VIRCHOWS ARCHIV, 2019, 475 (01) : 95 - 104
  • [5] The methyltransferases enhancer of zeste homolog (EZH) 1 and EZH2 control hepatocyte homeostasis and regeneration
    Bae, Woo Kyun
    Kang, Keunsoo
    Yu, Ji Hoon
    Yoo, Kyung Hyun
    Factor, Valentina M.
    Kaji, Kosuke
    Matter, Matthias
    Thorgeirsson, Snorri
    Hennighausen, Lothar
    FASEB JOURNAL, 2015, 29 (05) : 1653 - 1662
  • [6] The role of EZH1 and EZH2 in development and cancer
    Lee, Soo Hyun
    Li, Yingying
    Kim, Hanbyeol
    Eum, Seounghyun
    Park, Kyumin
    Lee, Chul-Hwan
    BMB REPORTS, 2022, 55 (12) : 595 - 601
  • [7] Enhancer of Zeste Homolog 2 (EZH2) in Malignant Progression of Gallbladder Carcinoma
    Behera, Gayatri
    Mitra, Suvradeep
    Mishra, Tushar S.
    Purkait, Suvendu
    JOURNAL OF GASTROINTESTINAL CANCER, 2021, 52 (03) : 1029 - 1034
  • [8] The Roles of the Histone Protein Modifier EZH2 in the Uterus and Placenta
    Mesa, Ana M.
    Rosenfeld, Cheryl S.
    Tuteja, Geetu
    Medrano, Theresa, I
    Cooke, Paul S.
    EPIGENOMES, 2020, 4 (03)
  • [9] Ezh2 is not required for cardiac regeneration in neonatal mice
    Ahmed, Abdalla
    Wang, Tao
    Delgado-Olguin, Paul
    PLOS ONE, 2018, 13 (02):
  • [10] EZH2 in hepatocellular carcinoma: progression, immunity, and potential targeting therapies
    Wang, Bohan
    Liu, Yachong
    Liao, Zhibin
    Wu, Haofeng
    Zhang, Bixiang
    Zhang, Lei
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2023, 12 (01)